Prevnar 20 4.4 mcg (Pneumococcal Polysaccharide Serotype 6b SUSPENSION) 4.4 MCG

PREVNAR 20 is a pneumococcal vaccine designed to help prevent infections caused by the pneumococcus bacteria. This 4.4 mcg suspension is administered intramuscularly and is suitable for individuals at risk of pneumococcal disease.

Strength

4.4 MCG

Pack Size

1 PRE-FILLED SYR/10 PRE-FILL SYR

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PREVNAR 20 is used to protect against pneumococcal infections, which can lead to conditions like pneumonia, meningitis, and bloodstream infections. This vaccine targets specific serotypes of the pneumococcus bacteria, including serotype 6B. It is often recommended for individuals who are at higher risk of contracting pneumococcal diseases, such as those with weakened immune systems or certain chronic health conditions.

Side Effects

Common effects of PREVNAR 20 may include mild redness, swelling, or pain at the injection site. Some individuals might experience temporary fever, fatigue, or muscle aches following vaccination. These effects are generally mild and short-lived.

Precautions & Warnings

PREVNAR 20 should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform your healthcare provider about any current illnesses or allergies before receiving the vaccine.

Avoid Interactions

PREVNAR 20 may interact with other vaccines or medications. It is generally recommended to space out the administration of other vaccines. Always consult a healthcare provider for personalized advice regarding potential interactions.

Frequently Asked Questions

PREVNAR 20 is used to help prevent infections caused by the pneumococcus bacteria, including pneumonia, meningitis, and bloodstream infections.

PREVNAR 20 is administered as an intramuscular injection.

Common side effects may include mild redness, swelling, or pain at the injection site, as well as temporary fever, fatigue, or muscle aches.

Individuals with a history of severe allergic reactions to any component of the vaccine should avoid PREVNAR 20.

It is important to consult a healthcare provider for personalized advice regarding potential interactions with other medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.